Valuation : Bayer AG

Market Cap 48.02B 55.74B 45.33B 41.26B 77.1B 5,322B 77.88B 539B 207B 2,708B 209B 205B 8,608B P/E 2026 *
22x
P/E 2027 * 15.9x
Enterprise Value 77.97B 90.5B 73.6B 66.99B 125B 8,642B 126B 876B 337B 4,397B 340B 332B 13,978B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.59x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.15%
1 day-1.14%
1 week-0.98%
Current month-0.69%
1 month-2.23%
3 months+37.22%
6 months+29.56%
Current year+31.59%
1 week 48.3
Extreme 48.3
49.73
1 month 47.22
Extreme 47.22
50.16
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 31/05/2023
Director of Finance/CFO 57 31/05/2026
Chief Tech/Sci/R&D Officer 59 31/01/2021
Director TitleAgeSince
Director/Board Member 56 31/03/2012
Director/Board Member 61 31/03/2017
Chairman 68 27/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-0.98%+72.48%-2.97% 56.24B
-0.11%-3.20%+49.61%+91.49% 1,002B
-0.27%-3.22%+50.51%+65.89% 644B
+1.63%-2.57%+21.19%+71.12% 443B
-0.63%-1.06%+28.11%+34.59% 343B
+0.43%-14.61%+9.88%+27.26% 262B
+0.93%-1.82%-1.82%+8.41% 245B
-2.25%-13.63%+36.61%+47.43% 212B
-0.90%-5.09%-15.47%-57.75% 199B
-0.58%-3.21%+25.10%+90.54% 181B
Average -0.29%-4.48%+27.62%+37.60% 358.59B
Weighted average by Cap. -0.07%-4.17%+32.54%+56.17%

Financials

2026 *2027 *
Net sales 45.78B 53.13B 43.21B 39.33B 73.5B 5,073B 74.23B 514B 198B 2,581B 200B 195B 8,206B 46.99B 54.54B 44.35B 40.37B 75.44B 5,207B 76.2B 528B 203B 2,650B 205B 200B 8,423B
Net income 2.14B 2.49B 2.02B 1.84B 3.44B 237B 3.47B 24.06B 9.25B 121B 9.34B 9.13B 384B 2.94B 3.41B 2.77B 2.52B 4.72B 326B 4.76B 33B 12.69B 166B 12.81B 12.52B 527B
Net Debt 29.95B 34.76B 28.27B 25.73B 48.09B 3,320B 48.57B 336B 129B 1,689B 131B 128B 5,369B 26.82B 31.13B 25.32B 23.04B 43.07B 2,973B 43.5B 301B 116B 1,513B 117B 114B 4,808B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
10/09/26 €48.70 -1.14% 2,214,646
09/09/26 €49.26 -0.30% 2,105,631
08/09/26 €49.41 +1.44% 1,982,797
07/09/26 €48.71 -0.29% 959,766
04/09/26 €48.85 -0.99% 1,533,698
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.70EUR
Average target price
58.22EUR
Spread / Average Target
+19.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!